Diabetes, Vol 49, Issue 5 863-871, Copyright © 2000 by American Diabetes Association

ARTICLES

Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells

HJ Goldberg, J Scholey and IG Fantus
Department of Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.

Increased flux through the hexosamine biosynthetic pathway is associated with altered gene expression. To investigate the underlying mechanisms, we treated glomerular mesangial cells with glucosamine and studied the regulation of the plasminogen activator inhibitor (PAI)-1 gene. Incubating mesangial cells with 2 mmol/l glucosamine for 4 days resulted in a 3.1+/-0.4-fold increase in PAI-1 mRNA levels (P < 0.01) and a 33+/-9-fold increase in the activity of a transiently transfected PAI-1 promoter-luciferase reporter gene (P < 0.01). Cotransfection of an expression vector for a dominant-negative type II TGF-beta receptor with the PAI-1 promoter-reporter gene did not interfere with this effect of glucosamine. However, mutation of 2 putative Sp1 sites in the PAI-1 promoter, at -76 to -71 and -44 to -39, markedly reduced induction of PAI-1 luciferase activity by glucosamine, from 8.9+/-1.9-fold to 1.7+/-0.5-fold (P < 0.01). An electrophoretic mobility shift assay demonstrated that glucosamine increased Sp1 DNA binding by 31+/-11% (P < 0.05), implying that the effects of glucosamine were explained, in part, by changes in Sp1 DNA binding. High glucose (20 mmol/l) also activated the transiently transfected PAI-1 promoter (2.5+/-0.4-fold). This effect was diminished by mutation of both the PAI-1 promoter Sp1 sites (1.2+/-0.3-fold, P < 0.05). In addition, 6-diazo-5-oxo-L-norleucine, a glutamine:fructose-6-phosphate-amidotransferase inhibitor, blocked the induction by high glucose (4.7+/-0.8- to 0.9+/-0.1-fold, P < 0.01). These results indicate that stimulation of the PAI-1 promoter by both high glucose and glucosamine involves Sp1 and that the hexosamine pathway may be involved in the regulation of gene expression by high glucose in glomerular mesangial cells.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. Vij and P. L. Zeitlin Regulation of the ClC-2 Lung Epithelial Chloride Channel by Glycosylation of SP1 Am. J. Respir. Cell Mol. Biol., June 1, 2006; 34(6): 754 - 759. [Abstract] [Full Text] [PDF]

				H. J. Goldberg, C. I. Whiteside, G. W. Hart, and I. G. Fantus Posttranslational, Reversible O-Glycosylation Is Stimulated by High Glucose and Mediates Plasminogen Activator Inhibitor-1 Gene Expression and Sp1 Transcriptional Activity in Glomerular Mesangial Cells Endocrinology, January 1, 2006; 147(1): 222 - 231. [Abstract] [Full Text] [PDF]

				F. H. Einstein, G. Atzmon, X.-m. Yang, X.-H. Ma, M. Rincon, E. Rudin, R. Muzumdar, and N. Barzilai Differential Responses of Visceral and Subcutaneous Fat Depots to Nutrients Diabetes, March 1, 2005; 54(3): 672 - 678. [Abstract] [Full Text] [PDF]

				C. Bouche, S. Serdy, C. R. Kahn, and A. B. Goldfine The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes Endocr. Rev., October 1, 2004; 25(5): 807 - 830. [Abstract] [Full Text] [PDF]

				H. S. Lee, K. C. Moon, C. Y. Song, B. C. Kim, S. Wang, and H. K. Hong Glycated albumin activates PAI-1 transcription through Smad DNA binding sites in mesangial cells Am J Physiol Renal Physiol, October 1, 2004; 287(4): F665 - F672. [Abstract] [Full Text] [PDF]

				C. Weigert, K. Brodbeck, M. Sawadogo, H. U. Haring, and E. D. Schleicher Upstream Stimulatory Factor (USF) Proteins Induce Human TGF-{beta}1 Gene Activation via the Glucose-response Element-1013/-1002 in Mesangial Cells: UP-REGULATION OF USF ACTIVITY BY THE HEXOSAMINE BIOSYNTHETIC PATHWAY J. Biol. Chem., April 16, 2004; 279(16): 15908 - 15915. [Abstract] [Full Text] [PDF]

				H.-C. Chen and E. P. Feener MEK1,2 response element mediates angiotensin II--stimulated plasminogen activator inhibitor-1 promoter activation Blood, April 1, 2004; 103(7): 2636 - 2644. [Abstract] [Full Text] [PDF]

				L. P. Singh, K. Green, M. Alexander, S. Bassly, and E. D. Crook Hexosamines and TGF-{beta}1 use similar signaling pathways to mediate matrix protein synthesis in mesangial cells Am J Physiol Renal Physiol, February 1, 2004; 286(2): F409 - F416. [Abstract] [Full Text] [PDF]

				C. Brasse-Lagnel, A. Fairand, A. Lavoinne, and A. Husson Glutamine Stimulates Argininosuccinate Synthetase Gene Expression through Cytosolic O-Glycosylation of Sp1 in Caco-2 Cells J. Biol. Chem., December 26, 2003; 278(52): 52504 - 52510. [Abstract] [Full Text] [PDF]

				T.-J. Hsieh, P. Fustier, S.-L. Zhang, J. G. Filep, S.-S. Tang, J. R. Ingelfinger, I. G. Fantus, P. Hamet, and J. S. D. Chan High Glucose Stimulates Angiotensinogen Gene Expression and Cell Hypertrophy via Activation of the Hexosamine Biosynthesis Pathway in Rat Kidney Proximal Tubular Cells Endocrinology, October 1, 2003; 144(10): 4338 - 4349. [Abstract] [Full Text] [PDF]

				G. J. Parker, K. C. Lund, R. P. Taylor, and D. A. McClain Insulin Resistance of Glycogen Synthase Mediated by O-Linked N-Acetylglucosamine J. Biol. Chem., March 14, 2003; 278(12): 10022 - 10027. [Abstract] [Full Text] [PDF]

				C. Weigert, K. Klopfer, C. Kausch, K. Brodbeck, M. Stumvoll, H. U. Haring, and E. D. Schleicher Palmitate-Induced Activation of the Hexosamine Pathway in Human Myotubes: Increased Expression of Glutamine:Fructose-6-Phosphate Aminotransferase Diabetes, March 1, 2003; 52(3): 650 - 656. [Abstract] [Full Text] [PDF]

				C. Weigert, K. Brodbeck, F. C. Brosius III, M. Huber, R. Lehmann, U. Friess, S. Facchin, S. Aulwurm, H. U. Haring, E. D. Schleicher, et al. Evidence for a Novel TGF-{beta}1-Independent Mechanism of Fibronectin Production in Mesangial Cells Overexpressing Glucose Transporters Diabetes, February 1, 2003; 52(2): 527 - 535. [Abstract] [Full Text] [PDF]

				H. J. Goldberg, C. I. Whiteside, and I. G. Fantus The Hexosamine Pathway Regulates the Plasminogen Activator Inhibitor-1 Gene Promoter and Sp1 Transcriptional Activation through Protein Kinase C-beta I and -delta J. Biol. Chem., September 6, 2002; 277(37): 33833 - 33841. [Abstract] [Full Text] [PDF]

				D. A. McClain, W. A. Lubas, R. C. Cooksey, M. Hazel, G. J. Parker, D. C. Love, and J. A. Hanover Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia PNAS, August 6, 2002; 99(16): 10695 - 10699. [Abstract] [Full Text] [PDF]

				L. R. James, D. Tang, A. Ingram, H. Ly, K. Thai, L. Cai, and J. W. Scholey Flux Through the Hexosamine Pathway Is a Determinant of Nuclear Factor {kappa}B- Dependent Promoter Activation Diabetes, April 1, 2002; 51(4): 1146 - 1156. [Abstract] [Full Text] [PDF]

				W.-Q. Ding, E. Holicky, and L. J. Miller Glucose and forskolin regulate IAPP gene expression through different signal transduction pathways Am J Physiol Endocrinol Metab, November 1, 2001; 281(5): E938 - E945. [Abstract] [Full Text] [PDF]

				L. P. Singh, J. Andy, V. Anyamale, K. Greene, M. Alexander, and E. D. Crook Hexosamine-Induced Fibronectin Protein Synthesis in Mesangial Cells Is Associated With Increases in cAMP Responsive Element Binding (CREB) Phosphorylation and Nuclear CREB: The Involvement of Protein Kinases A and C Diabetes, October 1, 2001; 50(10): 2355 - 2362. [Abstract] [Full Text]

				I. Gabriely, X. M. Yang, J. A. Cases, X. H. Ma, L. Rossetti, and N. Barzilai Hyperglycemia modulates angiotensinogen gene expression Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2001; 281(3): R795 - R802. [Abstract] [Full Text] [PDF]

				C. Banfi, P. Eriksson, G. Giandomenico, L. Mussoni, L. Sironi, A. Hamsten, and E. Tremoli Transcriptional Regulation of Plasminogen Activator Inhibitor Type 1 Gene by Insulin: Insights Into the Signaling Pathway Diabetes, July 1, 2001; 50(7): 1522 - 1530. [Abstract] [Full Text] [PDF]